NIH-funded research R01 grant

Brain cells that help raise blood sugar when it drops

Official title: GABA neurons in the ventromedial hypothalamus contribute to the counterregulatory response

Funded at Lsu Pennington Biomedical Research Ctr · NIH-11323066 · Data updated 2026-11-12

This project looks at a specific group of brain cells that sense low blood sugar and help trigger the body's response, which could matter for people who get dangerous hypoglycemia.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionLsu Pennington Biomedical Research Ctr
NIH-funded
Lab location1 site (Baton Rouge, United States)
Project startApril 1, 2022
Project endMarch 31, 2027
Funding year2026
Award (this year)$397,707
NIH project number5R01DK129548-05
Project IDNIH-11323066 on NIH RePORTER

Who could benefit from this research

Could help

People with type 1 diabetes or insulin-treated type 2 diabetes who experience recurrent or severe hypoglycemia would be the most likely candidates for future studies based on this research.

Less likely to help

People without blood sugar problems or whose symptoms are not caused by hypoglycemia are unlikely to benefit from this work.

What this research studies

Researchers will focus on a small population of GABA-producing neurons in the ventrolateral part of the ventromedial hypothalamus that appear to change activity when glucose falls. In animal models they will watch these cells' activity with fiber photometry and electrophysiology, control them with optogenetics, profile their genes using Patch-seq, and alter genes with CRISPR. The team will measure how turning these cells on or off affects hormone release and blood glucose recovery after low blood sugar. The goal is to reveal mechanisms that could point to new ways to prevent or treat severe hypoglycemia.

Why it matters

Potential benefit: If successful, this work could point to new approaches to prevent or treat dangerous low blood sugar in people with diabetes.

How similar studies have gone: Other studies have shown hypothalamic neurons help trigger counterregulation, but targeting this specific GABAergic neuron population is a newer and less-tested approach.

Where this research is happening

  • Lsu Pennington Biomedical Research Ctr
    Baton Rouge, United States
    Active

Researchers

  • Principal investigator: He, Yanlin — Lsu Pennington Biomedical Research Ctr
  • Study coordinator: He, Yanlin

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.